MedPath

ASTELLAS PHARMA HONG KONG COMPANY LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

PPB:21

Drug Approvals

VEOZA TABLETS 45MG

Approval Date
Apr 24, 2025
PPB

PADCEV POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 30MG

Approval Date
Jul 10, 2023
PPB

PADCEV POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG

Approval Date
Jul 10, 2023
PPB

XOSPATA TABLETS 40MG

Approval Date
Dec 15, 2021
PPB

XTANDI CAPSULES 40MG

Approval Date
Mar 4, 2015
PPB

BETMIGA PROLONGED-RELEASE TAB 25MG

Approval Date
Dec 17, 2013
PPB

BETMIGA PROLONGED-RELEASE TAB 50MG

Approval Date
Dec 17, 2013
PPB

FEBURIC TABLETS 80 MG

Approval Date
Mar 22, 2012
PPB

FEBURIC TABLETS 120 MG

Approval Date
Mar 22, 2012
PPB

ADVAGRAF PROLONGED-RELEASE HARD CAP 5MG

Approval Date
May 15, 2008
PPB
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.